Suppr超能文献

原发性卵巢功能不全患者的自身免疫和免疫特征综述。

A review of autoimmunity and immune profiles in patients with primary ovarian insufficiency.

机构信息

Departments of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun, China.

Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University, School of Medicine, Hangzhou, China.

出版信息

Medicine (Baltimore). 2022 Dec 23;101(51):e32500. doi: 10.1097/MD.0000000000032500.

Abstract

Primary ovarian insufficiency (POI) is a complicated clinical syndrome characterized by progressive deterioration of ovarian function. Autoimmunity is one of the main pathogenic factors affecting approximately 10% to 55% of POI cases. This review mainly focuses on the role of autoimmunity in the pathophysiology of POI and the potential therapies for autoimmunity-related POI. This review concluded that various markers of ovarian reserve, principally anti-Müllerian hormone, could be negatively affected by autoimmune diseases. The presence of lymphocytic oophoritis, anti-ovarian autoantibodies, and concurrent autoimmune diseases, are the main characteristics of autoimmune POI. T lymphocytes play the most important role in the immune pathogenesis of POI, followed by disorders of other immune cells and the imbalance between pro-inflammatory and anti-inflammatory cytokines. A comprehensive understanding of immune characteristics of patients with autoimmune POI and the underlying mechanisms is essential for novel approaches of treatment and intervention for autoimmune POI.

摘要

原发性卵巢功能不全(POI)是一种以卵巢功能进行性恶化为特征的复杂临床综合征。自身免疫是影响约 10%至 55%的 POI 病例的主要致病因素之一。本综述主要关注自身免疫在 POI 病理生理学中的作用以及针对自身免疫相关 POI 的潜在治疗方法。本综述得出结论,各种卵巢储备标志物,主要是抗苗勒管激素,可能会受到自身免疫性疾病的负面影响。淋巴细胞性卵巢炎、抗卵巢自身抗体和同时存在的自身免疫性疾病是自身免疫性 POI 的主要特征。T 淋巴细胞在 POI 的免疫发病机制中起着最重要的作用,其次是其他免疫细胞的紊乱以及促炎和抗炎细胞因子之间的失衡。全面了解自身免疫性 POI 患者的免疫特征及其潜在机制,对于自身免疫性 POI 的新型治疗和干预方法至关重要。

相似文献

1
A review of autoimmunity and immune profiles in patients with primary ovarian insufficiency.
Medicine (Baltimore). 2022 Dec 23;101(51):e32500. doi: 10.1097/MD.0000000000032500.
2
Autoimmune primary ovarian insufficiency.
Autoimmun Rev. 2014 Apr-May;13(4-5):427-30. doi: 10.1016/j.autrev.2014.01.003. Epub 2014 Jan 10.
3
Insights into the autoimmune aspect of premature ovarian insufficiency.
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101323. doi: 10.1016/j.beem.2019.101323. Epub 2019 Sep 16.
4
Identification of patients with primary ovarian insufficiency caused by autoimmunity.
Reprod Biomed Online. 2017 Oct;35(4):475-479. doi: 10.1016/j.rbmo.2017.06.010. Epub 2017 Jun 21.
5
Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal.
J Assist Reprod Genet. 2019 Nov;36(11):2207-2215. doi: 10.1007/s10815-019-01572-0. Epub 2019 Aug 22.
6
Premature ovarian insufficiency and autoimmune profiles: a prospective case-control study.
Climacteric. 2024 Apr;27(2):187-192. doi: 10.1080/13697137.2023.2287631. Epub 2023 Dec 18.
7
Premature ovarian insufficiency and autoimmune diseases.
Best Pract Res Clin Obstet Gynaecol. 2019 Oct;60:42-55. doi: 10.1016/j.bpobgyn.2019.07.008. Epub 2019 Jul 29.
8
Primary ovarian insufficiency: autoimmune causes.
Curr Opin Obstet Gynecol. 2010 Aug;22(4):277-82. doi: 10.1097/GCO.0b013e32833b6c70.
9
Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency.
J Autoimmun. 2012 Jun;38(4):315-21. doi: 10.1016/j.jaut.2012.01.015. Epub 2012 Feb 18.
10
High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency.
J Clin Endocrinol Metab. 2008 Apr;93(4):1263-9. doi: 10.1210/jc.2007-1675. Epub 2008 Jan 22.

引用本文的文献

1
Scoping Review of Letrozole in Assisted Reproductive Cycles: Efficacy and Outcomes Across Infertility Causes.
Healthcare (Basel). 2025 Jun 20;13(13):1486. doi: 10.3390/healthcare13131486.
2
The correlation between primary ovarian insufficiency, sex hormones and immune cells: a two-step Mendelian randomization study.
Front Endocrinol (Lausanne). 2025 Feb 14;16:1456273. doi: 10.3389/fendo.2025.1456273. eCollection 2025.
3
Post-pandemic insights on COVID-19 and premature ovarian insufficiency.
Open Life Sci. 2025 Jan 28;20(1):20221028. doi: 10.1515/biol-2022-1028. eCollection 2025.
4
Ovarian reserve in patients with Sjögren's syndrome: a cross-sectional study.
Clin Rheumatol. 2025 Jan;44(1):319-325. doi: 10.1007/s10067-024-07241-7. Epub 2024 Nov 22.
5
Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.
Adv Pharm Bull. 2024 Oct;14(3):543-557. doi: 10.34172/apb.2024.059. Epub 2024 Jul 31.
7
Network Pharmacology, Molecular Docking, and Experimental Validation on Guiluoshi Anzang Decoction Against Premature Ovarian Insufficiency.
Comb Chem High Throughput Screen. 2025;28(4):724-736. doi: 10.2174/0113862073291139240506114446.
8
Transient Premature Ovarian Insufficiency Post-COVID-19 Infection.
Cureus. 2023 Apr 10;15(4):e37379. doi: 10.7759/cureus.37379. eCollection 2023 Apr.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验